CIK 0001678660 · Non-accelerated filer<br>Smaller reporting company
Prelude Therapeutics Inc
Sign in to watch- Ticker
- PRLD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811384762
- Phone
- (302) 467-1280
- Business address
- 175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
- Former names
- Prelude Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 62 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-21 | Vaddi Krishna CEO | Purchase | +15,000 | $0.73 | $11K | 1,324,296 |
| 2025-03-20 | Vaddi Krishna CEO | Purchase | +5,416 | $0.73 | $4K | 1,309,296 |
| 2025-03-17 | Vaddi Krishna CEO | Purchase | +9,106 | $0.75 | $7K | 1,303,880 |
| 2025-03-14 | Vaddi Krishna CEO | Purchase | +29,999 | $0.75 | $23K | 1,294,774 |
| 2025-03-13 | Vaddi Krishna CEO | Purchase | +50,000 | $0.72 | $36K | 1,264,775 |
| 2025-03-12 | Vaddi Krishna CEO | Purchase | +47,500 | $0.71 | $34K | 1,214,775 |
| 2025-02-04 | Lim Bryant David CLO, CFO, Corp Sec. | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2025-02-04 | Scherle Peggy Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2025-02-04 | Combs Andrew Chief Chemistry Officer | Grant or award · Employee Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2025-02-04 | Huang Jane President, CMO | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2025-02-04 | Vaddi Krishna CEO | Grant or award · Employee Stock Option (right to buy) | +496,000 | 496,000 | ||
| 2025-01-04 | Huang Jane President, CMO | Option exercise | +9,375 | 72,716 | ||
| 2025-01-04 | Huang Jane President, CMO | Shares withheld for taxes | −3,859 | $1.39 | $5K | 68,857 |
| 2025-01-04 | Huang Jane President, CMO | Option exercise · Restricted Stock Unit | +9,375 | 46,875 | ||
| 2024-12-31 | Vaddi Krishna CEO | Purchase | +5,000 | $1.21 | $6K | 142,553 |
| 2024-12-30 | Vaddi Krishna CEO | Purchase | +10,000 | $1.20 | $12K | 137,553 |
| 2024-12-23 | Combs Andrew Chief Chemistry Officer | Purchase | +60,000 | $1.37 | $82K | 377,623 |
| 2024-12-20 | Combs Andrew Chief Chemistry Officer | Purchase | +3,075 | $1.15 | $4K | 317,623 |
| 2024-12-19 | Lim Bryant David CLO, Interim CFO, Corp Sec. | Purchase | +25,000 | $0.91 | $23K | 27,400 |
| 2024-12-19 | Vaddi Krishna CEO | Purchase | +6,888 | $0.89 | $6K | 127,553 |
Page 3 of 8 · 141 trades